Telix Completes Acquisition of Atlab for Prostate Cancer Program
Go back to Telix Completes Acquisition of Atlab for Prostate Cancer Program| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.09 +0.15 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.94 | 52 Week High | $2.18 | |||
| Open | $10.01 | 52 Week Low | $0.30 | |||
| Day High | $10.16 | P/E | N/A | |||
| Day Low | $9.95 | EPS | $-3.32 | |||
| Volume | 90,462 | |||||

